Oral Micronized Progesterone Food & Supplement Interactions

How Oral Micronized Progesterone Works

Oral micronized progesterone is bioidentical progesterone ground into particles smaller than 10 microns and suspended in peanut oil within a gelatin capsule. The micronization step is not cosmetic. Unprocessed progesterone is almost entirely destroyed by first-pass hepatic metabolism, leaving negligible circulating levels. Reducing particle size dramatically increases the surface area available for intestinal absorption, which raises bioavailability from roughly 5 to 10% for crystalline progesterone to approximately 10 to 20% for the micronized form. That difference is clinically meaningful.

First-Pass Metabolism and Active Metabolites

After absorption from the gut, oral micronized progesterone passes through the portal circulation and reaches the liver, where CYP3A4 enzymes convert most of it to 5α-dihydroprogesterone and then to allopregnanolone. Allopregnanolone is a positive allosteric modulator of GABA-A receptors, which explains the sedation that many patients report within 1 to 2 hours of the evening dose. This metabolite profile is quite different from synthetic progestogens like medroxyprogesterone acetate (MPA), which do not generate appreciable allopregnanolone.

The PEPI Trial (N=875), published in JAMA 1995, established that oral micronized progesterone provided endometrial protection equivalent to MPA while producing a significantly more favorable HDL-cholesterol profile over 3 years of follow-up (mean HDL increase of 0.03 mmol/L vs. A decrease of 0.23 mmol/L with MPA, P<0.001) (JAMA, 1995). That lipid advantage may partly reflect progesterone's lack of androgenic activity relative to MPA.

Why the Delivery Vehicle Matters

Prometrium capsules use peanut oil as the carrier solvent. Patients with IgE-mediated peanut allergy must not take Prometrium because anaphylaxis risk is real. Generic micronized progesterone capsules from compounding pharmacies sometimes use sunflower or sesame oil instead, which changes the allergy risk profile. Always confirm the carrier oil before prescribing or dispensing.

The Food Effect: Why You Should Always Take It With an Evening Snack

The single most actionable interaction with oral micronized progesterone is food co-ingestion. A pharmacokinetic study published in Fertility and Sterility found that administering 200 mg oral micronized progesterone with food raised Cmax approximately 3- to 4-fold and AUC (total drug exposure) by roughly 2.3-fold compared to the fasted state. The fasted half-life is about 16 to 18 hours, but absorption is so erratic without food that clinical endpoints can be missed.

Why Fat Content Is the Key Variable

The oil-based capsule formulation means fat stimulates bile secretion, which then emulsifies the peanut oil vehicle and improves dissolution in the duodenum. A 2001 pharmacokinetic analysis confirmed that the fat content of the meal, not total caloric load, drives the absorption increase. Protein-heavy meals with little fat produced a smaller food effect. The clinical implication: a handful of nuts, a glass of whole milk, or a small portion of avocado toast all qualify. A plain rice cake probably does not.

Bedtime Dosing as the Standard of Care

The North American Menopause Society (NAMS) clinical practice guideline and the Endocrine Society both recommend bedtime dosing for oral micronized progesterone. The rationale is twofold. Taking it with the evening meal satisfies the food requirement. Going to sleep 30 to 60 minutes later means the allopregnanolone-mediated sedation peaks during sleep rather than while driving or working. Patients who take it in the morning often report daytime drowsiness severe enough to discontinue therapy.

Grapefruit and Grapefruit Juice

Grapefruit is a meaningful interaction, not just a label boilerplate. Grapefruit and Seville orange juice contain furanocoumarins (principally bergamottin and 6',7'-dihydroxybergamottin) that irreversibly inhibit intestinal CYP3A4. Since oral micronized progesterone is a CYP3A4 substrate, co-ingestion with grapefruit juice raises circulating progesterone and allopregnanolone levels unpredictably.

What the Data Show

A study in the European Journal of Clinical Pharmacology found that a single 250 mL glass of grapefruit juice inhibited intestinal CYP3A4 activity by up to 47% for at least 24 hours (EJCP, 2000). Applied to oral micronized progesterone, this could translate to clinically significant increases in sedation, dizziness, and falls risk, particularly in older postmenopausal patients already on antihypertensives or sleep aids. Patients do not need to permanently avoid grapefruit, but they should not consume it within 4 hours of a progesterone dose, and daily grapefruit intake warrants a conversation about dose adjustment.

St. John's Wort: The Most Dangerous Supplement Interaction

St. John's Wort (Hypericum perforatum) is the most clinically serious supplement interaction for oral micronized progesterone. Hypericin and hyperforin, the active constituents, are potent inducers of CYP3A4 and P-glycoprotein (P-gp) via pregnane X receptor (PXR) activation.

Magnitude of the CYP3A4 Induction Effect

A controlled pharmacokinetic study in Clinical Pharmacology and Therapeutics found that 14 days of St. John's Wort at 300 mg three times daily reduced the AUC of the CYP3A4 probe drug midazolam by approximately 50%. Progesterone is a less sensitive CYP3A4 substrate than midazolam, but the same induction mechanism applies. Extrapolating from the midazolam data, chronic St. John's Wort use could plausibly reduce oral micronized progesterone exposure by 40 to 50%, potentially leaving the endometrium inadequately protected in postmenopausal women on estrogen therapy.

Clinical Decision Rule

St. John's Wort and oral micronized progesterone should not be taken together. Patients using St. John's Wort for mild depression should be counseled that SSRIs (e.g., escitalopram, sertraline) are both more effective by established trial data and free of this interaction. If a patient refuses to stop St. John's Wort, consider switching to a non-oral progesterone route (e.g., vaginal micronized progesterone gel) that bypasses hepatic first-pass metabolism and CYP3A4 entirely.

Alcohol

Alcohol deserves its own section because it is so commonly overlooked. Ethanol does not significantly alter progesterone pharmacokinetics, but it compounds the CNS-depressant effects of allopregnanolone. The GABA-A receptor is the shared pharmacodynamic target. Even 1 to 2 standard drinks taken within 2 hours of oral micronized progesterone can produce disproportionate sedation, cognitive slowing, and coordination impairment.

A study in Psychopharmacology demonstrated that allopregnanolone at plasma concentrations achievable after a 200 mg oral progesterone dose produced EEG changes comparable to a low dose of diazepam. Adding alcohol shifts the dose-response curve leftward, meaning less alcohol is needed to reach a sedating threshold. Patients should avoid alcohol on the evening they take their progesterone dose.

CNS-Active Supplements: Valerian, Kava, and Melatonin

Valerian Root

Valerian (Valeriana officinalis) extracts appear to modulate GABA-A receptors through mechanisms similar, though not identical, to benzodiazepines. A systematic review in the American Journal of Medicine found that valerian modestly improves sleep quality, but the combination with allopregnanolone from oral micronized progesterone may produce additive sedation. No head-to-head pharmacokinetic trial exists for this combination. Given the plausible additive mechanism, patients should be advised to separate valerian supplementation from their progesterone dose by at least 4 to 6 hours or to use it only on nights when they do not take progesterone.

Kava (Piper methysticum)

Kava is a stronger concern. Kavalactones potentiate GABA-A activity and also inhibit CYP3A4, CYP1A2, and CYP2D6. The CYP3A4 inhibition could raise progesterone and allopregnanolone levels, compounding sedation and CNS depression risk. The FDA issued a consumer advisory in 2002 linking kava to severe hepatotoxicity. Patients taking oral micronized progesterone should avoid kava entirely.

Melatonin

Melatonin at physiologic doses (0.5 to 1 mg) has no known pharmacokinetic interaction with progesterone. Higher doses (5 to 10 mg) used for jet lag or insomnia may compound sedation additively, not by a CYP mechanism but by simple pharmacodynamic overlap. A 0.5 to 1 mg dose taken 60 to 90 minutes before sleep is unlikely to cause a problem; 10 mg on the same evening as 200 mg progesterone is not recommended.

Magnesium, Vitamin B6, and Other "Progesterone Support" Supplements

The supplement market is full of products claiming to "support progesterone levels" or "balance hormones naturally." Magnesium glycinate and vitamin B6 are the most common. Neither has a meaningful pharmacokinetic interaction with oral micronized progesterone.

What the Evidence Shows

A 2017 systematic review in Nutrients found that magnesium deficiency correlates with lower progesterone levels in some populations, but oral magnesium supplementation in women with adequate baseline magnesium status did not significantly alter serum progesterone concentrations. Vitamin B6 at supplemental doses (25 to 100 mg/day) participates in steroid hormone metabolism but does not produce a clinically meaningful change in progesterone bioavailability. These supplements carry no contraindication but no documented combination either.

Vitex (Chasteberry)

Vitex agnus-castus is an important exception. Vitex binds to dopamine D2 receptors and modulates LH secretion, which may alter endogenous progesterone production in premenopausal women. In postmenopausal women on prescribed oral micronized progesterone, the dopaminergic effect is unlikely to be relevant, but a 2005 review in Phytomedicine noted that Vitex has agonist activity at mu-opioid and beta-opioid receptors, which could produce additive CNS effects. The combination has not been studied adequately. Caution is warranted until data exist.

Drug-Drug Interactions That Mirror Supplement Interactions

Understanding which drug classes interact helps clinicians predict unlabeled supplement interactions by analogy.

CYP3A4 Inducers (Reduce Progesterone Levels)

Rifampin, carbamazepine, phenytoin, and efavirenz all induce CYP3A4 through the same PXR mechanism as St. John's Wort. Any patient on these medications may have subtherapeutic progesterone levels despite standard dosing. A case report in Contraception (2012) documented breakthrough endometrial proliferation in a patient taking oral micronized progesterone concurrently with rifampin for tuberculosis. The same pharmacologic reasoning applies to high-dose licorice root (glycyrrhizin) at doses above 100 mg/day, which also induces hepatic enzymes in some studies.

CYP3A4 Inhibitors (Raise Progesterone Levels)

Ketoconazole, itraconazole, clarithromycin, and ritonavir inhibit CYP3A4 and may significantly raise progesterone and allopregnanolone exposure. Among supplements, grapefruit (discussed above) and berberine at high doses (500 mg three times daily) show moderate CYP3A4 inhibition in pharmacokinetic studies (Eur J Drug Metab Pharmacokinet, 2016). Patients taking high-dose berberine for blood sugar management should be counseled about the possible increase in sedation on progesterone nights.

Prescriber Decision Framework: CYP3A4 Interaction Risk Stratification

The table below categorizes the most common food, supplement, and drug co-exposures by interaction type and recommended clinical action.

| Co-exposure | Interaction Type | Net Effect on Progesterone | Recommended Action | |---|---|---|---| | High-fat meal | PK (absorption) | Increase (desired) | Take progesterone with evening meal or snack | | Grapefruit / Seville orange | CYP3A4 inhibition | Increase (undesired) | Avoid within 4 hours of dose | | St. John's Wort | CYP3A4 induction | Decrease (40 to 50%) | Contraindicated; switch supplement or route | | Rifampin, carbamazepine | CYP3A4 induction | Decrease (significant) | Dose adjustment or route switch | | Ketoconazole, ritonavir | CYP3A4 inhibition | Increase (significant) | Monitor for excess sedation | | Alcohol | Pharmacodynamic (GABA-A) | Additive CNS depression | Avoid same evening | | Kava | PK + pharmacodynamic | Increase + additive sedation | Contraindicated | | Valerian | Pharmacodynamic (GABA-A) | Additive sedation | Separate by 4 to 6 hours | | Berberine (high dose) | CYP3A4 inhibition (moderate) | Possible increase | Caution; monitor sedation | | Magnesium, B6, melatonin (low dose) | No significant interaction | Neutral | No restriction | | Vitex (chasteberry) | Pharmacodynamic (opioid/dopamine) | Unknown | Use caution; insufficient data |

Peanut Allergy: An Absolute Contraindication Often Missed at Intake

Prometrium 100 mg and 200 mg capsules contain peanut oil as the solvent. This is not a trace contaminant. The FDA-approved prescribing information for Prometrium explicitly states that the drug is contraindicated in patients with known peanut allergy. Clinicians conducting telehealth intake must ask directly about peanut allergy before prescribing Prometrium. A standard allergy field asking for "food allergies" is not always sufficient because some patients do not list peanut separately if they believe it is obvious.

Patients with peanut allergy who need oral micronized progesterone should receive a compounded formulation in a non-peanut carrier oil (sunflower or sesame oil are the most common alternatives). Confirm with the compounding pharmacy what oil is used and document the discussion.

Practical Dosing Guidance Incorporating Food and Supplement Considerations

Standard Postmenopausal HRT Protocol

The most widely used continuous regimen is 100 mg oral micronized progesterone nightly, taken with a small evening snack containing at least 10 to 15 g of fat, at bedtime. The cyclic regimen uses 200 mg nightly for 12 consecutive days per calendar month. Both regimens showed endometrial safety in the PEPI Trial (JAMA, 1995), where no endometrial hyperplasia was found in the oral micronized progesterone arms over 3 years (0/174 patients vs. 1/174 in the placebo arm, a statistically non-significant difference confirming protection).

Checklist Before First Prescription

1. Ask specifically about peanut allergy. Prescribe compounded formulation if positive.
2. Screen for St. John's Wort, kava, and valerian use.
3. Ask about daily grapefruit or Seville orange consumption.
4. Ask about nightly alcohol use.
5. Note all CYP3A4-interacting medications (antifungals, macrolide antibiotics, anticonvulsants, rifampin, protease inhibitors).
6. Counsel on bedtime dosing with a fatty evening snack and document the conversation.

The Endocrine Society Clinical Practice Guideline on Menopause states: "Progesterone (micronized) is preferred over synthetic progestogens for women who are candidates for progestogen therapy, given its more favorable metabolic profile." That preference holds, but only if the prescriber accounts for the food and supplement variables that govern its absorption and metabolism.